AMGN Congressional Stock Trades & Insider Buying (2026)
Quick Facts & Defense Contracting Direct Answers
How much does AMGEN INC receive in federal government contracts?
AMGEN INC has no tracked prime federal contract obligations in official FPDS and USAspending data; Gemral Edge tracks it primarily for congressional trading activity and technology-adoption signals.
Which congressional lawmakers trade AMGEN INC (AMGN) stock?
Public Periodic Transaction Reports (PTR) under the STOCK Act record transactions in AMGEN INC (AMGN) by members of Congress including Ro Khanna, David J Taylor, Marjorie Taylor Greene.
How are federal defense contracts mapped to AMGEN INC on Gemral Edge?
Gemral Edge programmatically reconciles prime award obligations from SAM.gov, USAspending, and FPDS through corporate parent CAGE and UEI hierarchies directly to ticker AMGN.
Congressional Stock Trading Activity in AMGN
Disclosed stock purchases and sales by members of Congress and spouses involving AMGEN INC securities under the STOCK Act:
| Lawmaker | Party-State | Chamber | Transaction Date | Action | Disclosed Range | Est. Return |
|---|---|---|---|---|---|---|
| Ro Khanna | D-CA | HOUSE | 2026-09-04 | BUY | $1K – $15K | -2.6% |
| David J. Taylor | R-OH | HOUSE | 2026-09-22 | BUY | $1K – $15K | +5.4% |
| David J. Taylor | R-OH | HOUSE | 2026-08-26 | SELL | $1K – $15K | -1.8% |
| David J. Taylor | R-OH | HOUSE | 2026-08-26 | SELL | $1K – $15K | -1.8% |
| Sheldon Whitehouse | D-RI | SENATE | 2026-08-12 | SELL | $1K – $15K | +3.9% |
| Ro Khanna | D-CA | HOUSE | 2026-07-20 | SELL | $1K – $15K | +18.8% |
| Ro Khanna | D-CA | HOUSE | 2026-07-08 | BUY | $1K – $15K | +17.5% |
| Alan Armstrong | R-OK | SENATE | 2026-03-27 | SELL | $15K – $50K | +24.0% |
| Ro Khanna | D-CA | HOUSE | 2026-06-30 | BUY | $1K – $15K | +19.4% |
| Ro Khanna | D-CA | HOUSE | 2026-06-16 | BUY | $1K – $15K | +24.3% |
| Ro Khanna | D-CA | HOUSE | 2026-06-02 | BUY | $1K – $15K | +31.8% |
| David J. Taylor | R-OH | HOUSE | 2026-06-05 | BUY | $1K – $15K | +23.7% |
| Ro Khanna | D-CA | HOUSE | 2026-05-27 | BUY | $15K – $50K | +28.7% |
| Ro Khanna | D-CA | HOUSE | 2026-05-15 | SELL | $15K – $50K | +32.5% |
| Ro Khanna | D-CA | HOUSE | 2026-05-01 | BUY | $15K – $50K | +31.1% |
AMGEN INC (AMGN) has no prime federal contract obligations currently recorded in Gemral Edge's dataset (FPDS / USAspending). Its Gemral Edge profile is monitored primarily for congressional stock-trading disclosures and enterprise technology-adoption signals rather than direct federal procurement.
Federal contracts represent substantial multi-year revenue visibility for prime contractors and defense suppliers. Gemral Edge continuously reconciles federal award obligations from the Federal Procurement Data System (FPDS) and USAspending with congressional disclosures, tracking capital flow from policy authorization through corporate execution.
Verified from official public disclosure — record AMGN-CONGRESS-DISCLOSURE
Unified Ticker Intelligence Dossier (AMGN)
Synthesis: Mã AMGN ghi nhận dữ liệu hoạt động tổng hợp qua các kênh công quyền và dòng tiền.
Temporal Context: Ghi nhận sự kiện và luồng thông tin mới trong 365 ngày qua đối với AMGN.
Data Coverage & Verification: Overall coverage score: 50% across 6 pillars (Government, Policy, Flow, Management, Catalysts, Historical). Verified by 2 independent statutory data sources.
AMGN insider buying and selling over the past year
Insiders at AMGEN INC only sold stock in the open market over the past year: 5 Form 4 sales totaling $24.82M, against no open-market purchases.
None of the 5 sales were flagged as Rule 10b5-1 plan trades, meaning each one was a discretionary decision at the time of filing. Activity clustered in 2025-11 (3 trades) and 2026-02 (2 trades); the latest filing in this window is dated 2026-02-26. The average open-market sale price was $372.17; the last close of $432.49 is 16.2% above that level, so sellers left upside on the table. The single largest trade was a sale of 54,792 shares worth $20.77M on 2026-02-26. Since the most recent filing the stock has moved +14.0%, from $379.33.
| Trade date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| 2026-02-26 | Sell | 54,792 | $379.12 | $20.77M | 0000318154-26-000012 |
| 2025-11-12 | Sell | 6,879 | $336.83 | $2.32M | 0000318154-25-000081 |
| 2025-11-20 | Sell | 3,139 | $337.26 | $1.06M | 0000318154-25-000083 |
| 2026-02-19 | Sell | 1,000 | $375.79 | $375.8K | 0000318154-26-000011 |
| 2025-11-12 | Sell | 890 | $336.24 | $299.3K | 0000318154-25-000082 |
Where AMGN trades relative to its one-year range
AMGEN INC closed at $432.49 on 2026-10-16, inside a one-year range of $291.16 to $444.12. That puts the stock near the top of its range, at 92.4% of the distance from low to high. Over one year the share price moved +46.2%, and over roughly three months +18.1%. Average daily volume over the last month was about 3,106,504 shares.
Across 137 companies in the same SEC industry group (SIC 28) with a full year of prices in Gemral Edge, the median one-year return was +12.0%. AMGN is ahead of that median and beat 83% of that peer group on this measure.
Members of Congress who traded AMGN
STOCK Act disclosures show 65 trades in AMGN by 22 members of Congress over five years (36 purchases, 29 sales), most recently on 2026-09-22. The most active traders were Ro Khanna (D-CA), 19 trades; David J. Taylor (R-OH), 9 trades; Marjorie Taylor Greene (R-GA), 4 trades; Tommy Tuberville (R-AL), 4 trades; Jefferson Shreve (R-IN), 3 trades.
By party the trades split 35 by Republicans, 30 by Democrats; by chamber, 58 from the House, 7 from the Senate.
AMGN lobbying disclosures
AMGEN INC appears in 20 Lobbying Disclosure Act filings between 2018 and 2018, with $4.15M in reported lobbying spend.
Compare AMGN with indexed peers from the same industry group
These peers have full Gemral Edge dossiers and the closest one-year price move to AMGN:
- LLY one-year return +53.4%
- REGN one-year return +38.9%
- BMY one-year return +37.7%
- DOW one-year return +36.7%
- KVUE one-year return +34.0%
Sources and method
Every figure above is computed from public filings stored in Gemral Edge, not estimated. Insider figures count only open-market purchases and sales reported on SEC Form 4; option exercises, grants and gifts are excluded because they do not reflect a decision to buy or sell at market prices.
- SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-02-26
- edge_prices_eod (end-of-day close) — as of 2026-10-16
- House PTR / Senate eFD disclosures (edge_congress_trades) — as of 2026-09-22
- Senate LDA filings (edge_lobbying_filings)
AMGN data questions
Are AMGN insiders buying or selling stock?
Insiders at AMGEN INC only sold stock in the open market over the past year: 5 Form 4 sales totaling $24.82M, against no open-market purchases.
What is the one-year price range for AMGN?
Based on end-of-day closes through 2026-10-16, AMGN traded between $291.16 and $444.12, last closing at $432.49.
Has any member of Congress traded AMGN stock?
Yes. 22 members disclosed 65 trades in AMGN over five years; the most recent disclosed trade date is 2026-09-22.
Which congressional committees and active lawmakers are linked to this sector?
Disclosed lawmakers and congressional committees holding policy jurisdiction, defense appropriations oversight, or direct capital exposure in AMGN:
- Ro Khanna (House) — Disclosed STOCK Act transactions (D-CA)
- David J. Taylor (House) — Disclosed STOCK Act transactions (R-OH)
- Sheldon Whitehouse (Senate) — Disclosed STOCK Act transactions (D-RI)
- Alan Armstrong (Senate) — Disclosed STOCK Act transactions (R-OK)
- Maria Elvira Salazar (House) — Disclosed STOCK Act transactions (R-FL)
- Julia Letlow (House) — Disclosed STOCK Act transactions (R-LA)
- Marjorie Taylor Greene (House) — Disclosed STOCK Act transactions (R-GA)
- Lisa C. McClain (House) — Disclosed STOCK Act transactions (R-MI)
Latest Real-Time Intelligence & Breaking Events
Live contract obligations, SEC filings, and procurement intelligence for AMGEN INC are monitored 24/7 on Gemral Edge Breaking News and Defense Radar.
Frequently asked questions
How much does AMGEN INC receive in federal government contracts?
AMGEN INC has no tracked federal contract obligations in Gemral Edge's dataset; its profile is monitored for congressional trading activity and technology-adoption signals rather than direct federal procurement.
Which congressional lawmakers trade AMGEN INC (AMGN) stock?
AMGEN INC (AMGN) stock transactions have been disclosed by members of Congress including Ro Khanna, David J Taylor, Marjorie Taylor Greene, Tommy Tuberville. Disclosures filed under the STOCK Act detail execution dates, asset classes, and statutory valuation ranges.
How are federal defense contracts resolved to AMGEN INC?
Gemral Edge maps prime award notices from the Federal Procurement Data System (FPDS) and USAspending through Ultimate Parent CAGE and UEI corporate hierarchies directly to parent ticker AMGN.
What technology stack signals are detected for AMGEN INC?
Active talent hiring requisitions and engineering role profiles are continuously monitored across public corporate job postings to track enterprise software adoption and technology migration patterns.
Data intelligence from public filings — not investment advice.
Explore Gemral Edge
- Lawmaker trading AMGN
- Lawmaker trading AMGN
- Lawmaker trading AMGN
- Lawmaker trading AMGN
- Lawmaker trading AMGN
- Sheldon Whitehouse — stock portfolio
- Alan Armstrong — stock portfolio
- Maria Elvira Salazar — stock portfolio
- Julia Letlow — stock portfolio
- Bank of Japan Yen Carry Trade Unwind Odds, Rate Hike Model…
- Bank Run Panic, CRE Debt Crisis & Deposit Safety Playbook
- BRICS Gold Currency & Global Dedollarization
- Capitol Trades leaderboard
- Federal contract explorer
- Lobbying velocity index
- Live signal radar
- Macro & liquidity radar
- 2026 Senate battleground
Risk Disclaimer
Trading and investing in digital assets, financial instruments, and predictive events involve substantial risk of loss and are not suitable for every investor. The predictive intelligence, probability distributions, historical precedents, and scenario modeling presented on this page are compiled for informational and research purposes only and do not constitute financial, investment, legal, or tax advice. Past performance and statistical precedents do not guarantee future outcomes. Always conduct independent due diligence before committing capital.